A great number of RNA-containing animal viruses encode polyproteins that are proteolytically cleaved by host or viral proteases to produce the mature viral products (7, 27) . This genetic strategy is exacerbated in picornaviruses, in which all of the proteins derive from a polyprotein precursor synthesized by a single initiation event (13, 27) . Such a polyprotein is not found in infected cells because it is proteolytically degraded while the nascent polypeptide chain is still attached to the ribosome (7, 27) . In poliovirus, proteases 2A pro and 3C pro (or 3CD pro ) accomplish all but one of the proteolytic cleavages of the polyprotein needed to produce mature viral proteins. The two proteinases belong to the family of serine-like proteinases (7) . In poliovirus 2A pro , the catalytic triad is formed by His-20, Asp-38, and Cys-109 (14, 42) . This active-site nucleophilic cysteine residue replaces the serine found in serine proteases (7) . 2A pro is responsible for two cleavages of the poliovirus polyprotein (7) . The first one, between P1 and 2A, releases from ribosomes all of P1, containing the four structural proteins (35) . A second cleavage catalyzed by 2A pro occurs on the 3CD precursor, between amino acids Y-148 and G-149 of 3D, to produce 3CЈ and 3DЈ (26) , two products with unknown functions (38) . In an alternative cleavage, 3CD is a substrate that allows 3C pro to produce itself and poliovirus RNA polymerase 3D pol . Apparently, the former cleavage event is not required for poliovirus growth in HeLa cells. A mutation (ThrAla) at position P2 produces a modified 3CD that is not a substrate for 2A pro (18) . Plaques are produced by this mutant in HeLa cells, leading to the conclusion that the 3CD cleavage by 2A pro was not important for the poliovirus life cycle, at least in tissue culture cells (18) . However, it is puzzling that this cleavage site is conserved in most virulent strains of poliovirus, whereas poliovirus type 1 Brumhilde, type 3 Sabin, and type 3 Leon appear not to produce 3CЈ and 3DЈ (18) .
In addition to the two cleavages produced by 2A pro on the poliovirus proteins, this protease may also degrade cellular proteins (36) . The best-illustrated case of a cellular protein being degraded by a viral protease is the cleavage of p220 (the gamma subunit of eukaryotic initiation factor 4), a component of eukaryotic initiation factor 4F, which is internally cleaved once by rhinovirus 2A pro (32, 33) . It is still unknown if poliovirus 2A pro cleaves p220 directly or by activating a cellular protease (39, 40) . It is still a matter of debate to what extent cleavage of p220 is responsible for the shutoff of host translation induced by poliovirus (34) . The suggestion that p220 cleavage would selectively impair the translation of capped mRNAs (8) has not been supported by more recent evidence indicating that the kinetics of p220 cleavage does not correlate with the shutoff of host translation by poliovirus (3, 6, 19, 28) .
The function of 2A pro may not be restricted to its role as a protease. Indications that the protein acts as a transactivator for the translation of its own mRNA (12) and that the protein is required for poliovirus RNA synthesis (23) have been reported recently. Although a number of poliovirus replicons lacking part of the entire P1 region replicate in cells, this ability is lost when 2A pro is deleted (11, 25) , strongly arguing in favor of the idea that the 2A pro function is required for events other than P1-2A cleavage. Elegant experiments constructing viable poliovirus with the encephalomyocarditis virus IRES sequence placed between P1 and 2A reinforced this idea (23, 38) . This hybrid poliovirus was unable to replicate the genome when the 2A pro sequence was deleted. Mutations in Cys-109 of 2A pro also abrogate the replication of minireplicons or hybrid poliovirus (23) , arguing that the protease function of 2A is not restricted to cleavage of the P1-2A junction but is necessary for another, unidentified event(s) involved in viral genome replication (38) . Therefore, the possibility is still open that other cleavage products of 2A pro are required for poliovirus RNA synthesis. Alternatively, it might be that 2A pro itself is endowed with other functions, for instance, the RNA-binding capacity necessary for genome replication (23) .
A number of 2A pro mutants have been generated, and their ability to cleave in cis and trans has been analyzed (38) . Many mutations in the catalytic triad, particularly in Cys-109, render this protease totally inactive, whereas mutations in other residues of the protein generate a 2A pro still able to cleave P1-2A in cis but devoid of p220 cleavage activity (14, 42) . This has been well illustrated in tyrosine residue 88 mutants, suggesting that this residue participates in substrate recognition (14, 42) . Since these studies were accomplished with 2A pro synthesized in vitro and all of the assays were done with cell-free systems, we considered it of interest to reconstruct polioviruses with tyrosine residue 88 replaced by other amino acids. We now report that one such mutant, Y88S, efficiently cleaves p220 in HeLa cells, but cleavage of 3CD does not occur. This mutant poliovirus shows defects in viral protein synthesis, transactivation of the poliovirus leader sequence, and plaque size, confirming a role of 2A pro in the stimulation of poliovirus mRNA translation during the virus replication cycle (12) .
After completion of this study, we learned that Yu et al. (41) also reconstructed a poliovirus with the Y88S mutation in 2A pro . Contrary to their previous report (42) , they observed cleavage of p220 with the in vitro-translated proteins from the mutated poliovirus RNA. Although they found some replication of viral RNA in transfected cells, they were unable to grow and recover virus. We have no explanation for their failure to isolate the poliovirus mutant described in the present work.
MATERIALS AND METHODS

Cells and viruses.
HeLa cells were maintained in Dulbecco modified Eagle medium supplemented with 10% calf serum (GIBCO) and incubated at 37ЊC in a 5% CO 2 atmosphere. Wild-type (WT) and mutant polioviruses were isolated from single plaques grown in HeLa cells after transfection with in vitro-synthesized RNA from plasmid pT7XLD (37) . To generate high-titer stocks, poliovirus was grown in Vero cells for two additional passages. In some experiments, poliovirus type 1, not derived from the infectious clone, was obtained and used as previously described (30) . Vesicular stomatitis virus was grown in BHK-21 cells as previously described (16) .
Bacterial strains, enzymes, and plasmid construction. All plasmids were isolated from Escherichia coli DH-5 and manipulated in accordance with standard procedures (31) . Restriction enzymes were purchased from New England Biolabs. T7 RNA polymerase, RNasin, and T4 DNA ligase were obtained from Promega. Avian myeloblastosis virus reverse transcriptase was from Seikagaku America, Inc. The infectious clone of poliovirus type 1 (pT7XLD) was generously provided by E. Wimmer (Stony Book, N.Y.). Plasmid pT75ЈNCpolioLUC was obtained with primers 5ЈLuc (GAC CCG GGC GAA GACGCCAAAAAC ATAAAGAAAGGCC) and 3ЈLuc (CCG CA AT ATTTGGACTTTCCGCCC), which were designed for PCR amplification of the coding region of the firefly luciferase gene (sequences underlined) from plasmid pDO432, provided by S. H. Howell (University of California, La Jolla). The resulting 1.6-kpb DNA fragment was digested with SmaI and SspI and ligated to plasmid pT75ЈNCpolio containing the 5Ј leader sequence of poliovirus type 1 (nucleotides 1 to 742) downstream of the T7 RNA polymerase promoter. The translation initiation codon of the luciferase gene starts at the same position as the poliovirus genome in the resulting construction. Plasmid KSLUC was obtained by subcloning the 1.8-kbp BamHI fragment from plasmid pDO432 into pBluescript KS (Stratagene). This plasmid contains the 5Ј leader sequence (80 nucleotides) of the luciferase gene. Plasmid pTM12C, containing the poliovirus 2C sequence under the control of the encephalomyocarditis virus 5Ј untranslated region, was obtained as previously described (1) . Plasmid pTM12A, containing the poliovirus 2A sequences or its variants, was made similarly.
Site-directed mutations of 2A pro . The 2A pro mutants were obtained by overlap extension with the PCR as previously described (15, 22) . One synthetic oligonucleotide containing four possible site-specific substitutions in nucleotides 3645 to 3647 from pT7XLD were generated (primer A: GCTGGGTAAG/A G/AGTTA TTAGCG). The first PCR was carried out under standard conditions with plasmid pT7XLD as the template, primer A, and primer 5Ј2AE1A (GGC CGG CC CG GGATTCGGACACCAAAAC), complementary to nucleotides 3386 to 3403 from pT7XLD (underlined). The amplified DNA fragment was extracted from agarose gels and mixed at a molar ratio of 10:1 with a DNA fragment encompassing nucleotides 3417 to 3925 from pT7XLD, and the second PCR was performed by overlap extension. The resulting DNA fragment was digested with MscI and subcloned into plasmid pBR322Polio2954-4600 containing the SnaBIBamHI fragment from pT7XLD. Mutant clones were screened by sequencing and introduced into full-length poliovirus cDNA with the enzyme BstEII.
In vitro transcription and RNA transfection. pT7XLD and the luciferasederived plasmids were linearized with EcoRI and SspI, respectively, and used as templates for in vitro transcription. The reaction mixtures contained 40 mM Tris-HCl (pH 7.9); 6 mM MgCl; 2 mM spermidine; 10 mM dithiothreitol; 1 mM each CTP, UTP, GTP, and ATP; 160 U of RNAsin RNase inhibitor (Promega); and 100 U of T7 RNA polymerase (Promega) and were incubated at 37ЊC for 120 min. Capped luciferase mRNAs were prepared in a similar fashion, except that 1 mM 7mG(5Ј)ppp(5Ј) (Biolabs) was also present. About 5 g of in vitrosynthesized, full-length poliovirus RNA was used to transfect HeLa cells in 60-mm-diameter plates at 50 to 60% confluence with lipofectin reagent (GIBCO BRL), and the plates were incubated at 37ЊC for several days. WT poliovirus RNA produced a total cytopathic effect (CPE) at 72 h after transfection, whereas mutant Y88S showed only a weak effect at that time. Several single plaques from both viruses were picked and amplified in Vero cells by two additional passages to obtain high-titer virus stocks. To verify the presence of the mutated 2A, the sequence was amplified from the extracted viral RNA by reverse transcriptase PCR and sequenced by the dideoxy method.
Virus infection of cell monolayers. HeLa or Vero cells were infected with WT or mutant virus in Dulbecco modified Eagle medium at the multiplicity of infection (MOI) indicated elsewhere in this report for each experiment. After 1 h of adsorption at 37ЊC (time zero of infection), the monolayers were washed and fresh medium containing 2% calf serum was added. To analyze one-step virus growth, cells growing in 24-well plates were infected at an MOI of 10 PFU per cell. At various times after infection, cells were scraped from the dishes and lysed by three cycles of freezing and thawing. Lysates were clarified by centrifugation at 3,000 rpm for 25 min in an SS-34 rotor, and virus titers were obtained by plaque assay on HeLa cells. . The samples were sonicated and heated at 90ЊC for 5 min. An aliquot was applied to an SDS-15% polyacrylamide gel and run overnight at 80 V. Fluorography was carried out in 1 M sodium salicylate. Finally, the gels were dried and exposed to X-ray film (Agfa) at Ϫ70ЊC.
Analysis of proteins by polyacrylamide gel electrophoresis (PAGE
Immunoblot analysis. Immunodetection of proteins with specific antisera was carried out with the ECL Western blotting (immunoblotting) detection kit (Amersham). Briefly, cellular extracts harvested in sample buffer were electrophoresed and transferred to a nitrocellulose membrane (Bio-Rad). After the nitrocellulose sheet was blocked with 5% nonfat milk in PBS for 1 h, the specific antiserum (anti-p220 or anti-3C) was added at a dilution of 1:1,000 in a PBS-1% nonfat milk solution and incubated for 2 h at room temperature. The blot was then washed three times with PBS containing 0.05% Tween 20 and incubated for 1 h with the second antibody (biotinylated anti-rabbit immunoglobulin antiserum). The blot was washed three times, and a streptavidin-peroxidase conjugate was added at a dilution of 1:20,000. After 1 h of incubation, the luminescence reaction was performed with 1 volume of solution A (100 mM Tris-HCl [pH 8], 5 mM H 2 O 2 ) mixed with 1 volume of solution B (2.5 mM luminol, 78 mM luciferin). The blot was air dried and exposed to X-ray film (Agfa) for several seconds to several minutes.
Measurement of viral RNA synthesis. Total poliovirus RNA synthesis was measured by determining the incorporation of [ 3 H]uridine into trichloroacetic acid-precipitable material from dactinomycin-treated cells as described previously (30) . To detect poliovirus positive-strand RNA, dot blot analysis was performed as follows. Total cytoplasmic RNA of poliovirus-infected cells was obtained by the Nonidet P-40 lysis method (9) . One-microgram samples of RNA were denatured in 10ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-7% (wt/vol) formaldehyde at 55ЊC for 1 h. The samples were bound to nitrocellulose filters by aspiration with a dot blot apparatus (Bio-Rad). Filters were dried at 80ЊC for 2 h and prehybridized at 55ЊC for 2 h in a solution containing 50% formamide, 5ϫ SSC, 50 mM Na 2 HPO 4 (pH 6.5), 0.1% SDS, 1 mM EDTA, 2.5ϫ Denhardt's solution, and 200 g of salmon sperm DNA per ml. Hybridization was continued overnight at 55ЊC in the same solution containing a 0.2-g/ml concentration of a biotinylated RNA probe generated by in vitro transcription of a poliovirus fragment cDNA encompassing nucleotides 2099 to 4600 subcloned in a Bluescript KS vector (Stratagene). Synthesis of the biotinylated riboprobe was carried out as recommended by the manufacturer (Clontech). After hybridization, the filters were washed four times in 0.1ϫ SSC-0.1% SDS at 65ЊC, air dried, and blocked in buffer B (PBS-0.05% Tween 20, 3% bovine serum albumin) at room temperature for 30 min. After incubation with a VOL. 69, 1995 POLIOVIRUS 2A pro MUTANT 6281 streptavidin-peroxidase conjugate (diluted 1:10,000) for 30 min in buffer A (PBS-0.05% Tween 20), the filters were washed extensively with the same buffer and detection was carried out as described for immunoblot analysis. Quantitation of specific RNA was performed by densitometric analysis with a 300A computing densitometer (Molecular Dynamics). Complementation assay. Two different assays were carried out to test the complementation of mutant 2A(Y88S) by WT poliovirus. To test the complementation for PFU formation, HeLa cells were simultaneously infected with 10 PFU of each virus per cell. After 6 or 8 h of incubation, the medium and intracellular virus were collected and plaque formation was assayed by the standard technique. To assay the effect of complementation on 3CD cleavage, cells were simultaneously infected with 10 PFU of each virus per cell. After 6 h of incubation at 37ЊC, the cell monolayer was dissolved in sample buffer and the proteins were separated by SDS-PAGE as described above. Immunoblot analysis with specific anti-3C serum was performed as described above.
Polysome analysis. HeLa cells (5 ϫ 10 7 ) were infected with WT poliovirus or mutant 2A(Y88S) at 50 PFU per cell as described above. At 4 h 40 min postinfection (p.i.), the cells were treated with 100 g of cycloheximide per ml; 5 min later, the cells were washed twice with PBS and lysed in 0.5 ml of polysome buffer (20 mM Tris-HCl [pH 7.6], 60 mM NaCl, 10 mM MgCl 2 , 0.5 mM EDTA, 2 mM dithiothreitol, 0.5% Nonidet P-40) supplemented with 100 g of cycloheximide per ml and 100 U of RNAsin. After 15 min of incubation on ice, the extracts were centrifuged at 12,000 rpm for 15 min in a microcentrifuge, and the resulting postmitochondrial supernatants were applied to a 7 to 47% sucrose gradient in polysome buffer. Centrifugation was done at 38,000 rpm for 110 min at 4ЊC in a Beckman TST 41.14 rotor. Gradients were fractionated with an ISCO UA-5 gradient fractionator, and the A 254 was recorded. Eight fractions were collected from each gradient and adjusted to 1% SDS, and total RNA was purified by phenol extraction and ethanol precipitation. The distribution of poliovirus-specific RNA in the different fractions was analyzed by dot blot hybridization as described above.
Transfection of in vitro-synthesized luciferase RNA molecules into HeLa cells. HeLa cells grown in 35-mm-diameter plates at 70 to 80% confluence were transfected with 1 g of uncapped 5ЈNCpolioLUC or capped LUC RNA transcripts derived from pT75ЈNCpolioLUC and KSLUC, respectively, made in vitro with 5 g of lipofectin reagent (GIBCO BRL). After 3 h of incubation at 37ЊC, the monolayers were washed with cold PBS and lysed in 200 l of buffer L (25 mM glycylglycine [pH 7.8], 1 mM dithiothreitol, 0.5% Triton X-100) for 10 min at 0ЊC. Nuclei and cell debris were pelleted by low-speed centrifugation, and a 20-l aliquot of the resulting supernatant was used to measure luciferase activity (6a) in a Monolight 2010 apparatus (Analytical Luminescence Laboratory). Luciferase activity was corrected by the amount of protein present in each sample as estimated by the Bio-Rad protein assay. To determine the effect of WT or mutant poliovirus infection on luciferase expression, the cells were infected with these viruses at an MOI of 50 PFU per cell and transfected 2 h later with the luciferase RNAs. Three hours posttransfection (5 h p.i.), extracts were made and luciferase activity was measured. pro Y-88 mutants showed such behavior, at least in cell-free systems (42) . Y-88 was mutated to F, S, P, and L, and the resulting 2A pro was inserted into the infectious poliovirus genome (Fig.  1) . RNA transcripts were generated by T7 RNA polymerase and transfected into HeLa cells, and single plaques were picked and amplified. The Y88F mutant behaved in the same way as WT poliovirus, in agreement with a recent report by Yu et al. (41) . However, mutants Y88P and Y88L were nonviable. Interestingly, mutant 2A(Y88S) had a small-plaque phenotype (Fig. 2B) , suggesting defects in 2A pro function. In contrast to our findings, Yu et al. (41) found that the 2A(Y88S) mutant did not produce plaques in COS cells, even after prolonged incubation. Although we have no explanation for their findings, it is possible that the different systems used could account for these differences.
RESULTS
Construction of poliovirus containing mutations at residue
Growth of 2A pro mutant Y88S. Initially, the growth characteristics of mutant 2A(Y88S) in HeLa cells were analyzed. The growth of Y88S in HeLa cells was restricted compared with that of WT poliovirus derived by transfection of RNA transcribed from plasmid pT7XLD (Fig. 2A) . The differences in virus growth were also apparent when the CPE was analyzed. Mutant 2A(Y88S) manifested a CPE in some HeLa cells of the culture only after prolonged incubation, while this effect was observed with WT poliovirus much earlier ( Fig. 2A) . Finally, the 2A(Y88S) mutant gave smaller plaques than did the WT in HeLa cells (Fig. 2B) . No differences were found in this behavior when the plaques were formed at 32 or 39ЊC, suggesting that 2A(Y88S) is not a temperature-sensitive mutant. The plaques formed by mutant Y88S were homogeneous, and less than 1% reversion to the WT phenotype was apparent.
Protein synthesis and cleavage of p220 and 3CD by the 2A pro Y88S mutant. To characterize the defect of the 2A(Y88S) mutant at the molecular level during the virus replication cycle, we started by analyzing the kinetics of protein synthesis of the 2A(Y88S) mutant in HeLa cells. Figure 3 shows that the kinetics of protein synthesis by the WT poliovirus and mutant 2A(Y88S) were similar during the initial hours of infection of HeLa cells, but after 4 h p.i. the kinetics differed. Viral protein synthesis by WT poliovirus peaked at 6 h p.i., while viral translation by the mutant virus decreased after 4 h p.i. (Fig. 3A) . Densitometric analysis of VP3 indicated that at 6 h p.i. the 2A(Y88S) mutant synthesized less than one-fifth of the VP3 of the WT poliovirus. It must be noted that viral protein synthesis by the WT poliovirus obtained after transfection of the RNA made by transcription of pT7XLD is slower than that of the adapted poliovirus routinely used in our laboratory. It is of interest that the 2A(Y88S) mutant synthesizes both P1 and 2A, indicating that 2A pro is active in cis and catalyzes the hydrolysis between P1 and itself. Close inspection of the protein patterns of the WT and the Y88S mutant shows that protein migrating the same as 3CЈ was absent in 2A(Y88S) mutant, suggesting a defect in 3CD cleavage by the mutated 2A pro (Fig. 3A) . Protein 3DЈ migrated together with VP2 and was not distinguishable.
To assay the cleavage of p220 by the WT and the Y88S mutant, the proteins present at different times during infection were transferred to a nitrocellulose membrane and immunoblotted with specific p220 antiserum (Fig. 3B ). Both the Y88S mutant and WT poliovirus extensively hydrolyzed p220 with similar kinetics (Fig. 3B) (Fig. 3A) . These results are striking because they illustrate and reinforce the idea that the specificity of 2A pro for substrates in trans can be altered in a selective way (42) (Fig. 4B) . Coinfection with both mutant 2A(Y88S) and our WT poliovirus gave rise to two bands, one of them corresponding to the 3CЈ from mutant 2A(Y88S) ( 3CЈ 2 ) (Fig. 4B) H]uridine at 3 to 4 and 4 to 5 h p.i. was half of that seen in cells infected with the WT virus. However, almost no differences were found during the initial 2 to 3 h p.i. or at later times (Fig. 5A) . Measurement of total viral RNA by dot blot analyses with a specific poliovirus riboprobe showed that HeLa cells infected with 2A(Y88S) contained about 50 to 70% of the positive-strand RNA of WT poliovirus (Fig. 5B) . Thus, the Y88S mutant makes less viral RNA than does the WT poliovirus in HeLa cells. These results may reflect a defective 2A pro activity of mutant 2A(Y88S) during RNA replication or a lower amount of other viral proteins made by the mutant virus that are needed for genome replication. It must be kept in mind that poliovirus RNA synthesis requires continuous viral protein synthesis (4) . Therefore, a decrease in viral protein synthesis would have repercussions in viral RNA synthesis.
Apart from the analysis of total poliovirus RNA, the distribution of viral RNA after polysome fractionation was determined (Fig. 6) . Lysates from cells infected with WT poliovirus or the 2A(Y88S) mutant were fractionated by sucrose gradient centrifugation. Both the optical density at 254 nm and the viral RNA present in each fraction were estimated. The amounts of ribosomal subunits (fractions 2 to 4) in the two lysates were similar, while the polysomal fraction (fractions 5 to 8) was more abundant in WT poliovirus-infected cells than in 2A(Y88S) mutant-infected cells (Fig. 6A) . In agreement with the data obtained on the polysomal profile, the amount of viral RNA from WT poliovirus was more abundant in all fractions of the gradient and particularly in the heavy fractions, which represent polysomes, than in the fractions from the 2A(Y88S) mutant ( Fig. 6B and C) . The highest amount of viral RNA in the 2A(Y88S) mutant was located in fractions 4 and 5, which probably represent monosomes and virion RNA. These results reinforce the idea that the viral RNA from the mutant virus participates to a lesser extent in translation than does WT poliovirus mRNA. Effects of guanidine on RNA and protein synthesis. To determine whether the primary defect of the 2A(Y88S) mutant is at the level of viral RNA replication or protein synthesis, the poliovirus RNA synthesis inhibitor guanidine was used. Addition of guanidine from about 2.5 h p.i. does not prevent the appearance of poliovirus proteins, while RNA synthesis is immediately halted (4, 17) . Thus, we reasoned that addition of guanidine at 3.5 h p.i. would still allow the synthesis of viral proteins under conditions in which no differences in viral RNA content are observed between the 2A(Y88S) mutant and WT poliovirus. Figure 7 shows that addition of guanidine at 3.5 h p.i. arrested the synthesis of viral RNA (Fig. 7C) and the infected cells continued with the same amount of viral RNA until 6.5 h p.i. (Fig. 7C) . Almost no difference in the total amount of poliovirus RNA was found between the WT and the mutant virus, and only a slight difference in the stability of viral RNA was observed (Fig. 7B) .
Analysis of the proteins synthesized by WT poliovirus in the presence of guanidine showed efficient synthesis of virus proteins at 3.5 to 4.5 h p.i. and a decline of viral translation in the subsequent 2 h (Fig. 7A ). This behavior may be due to sequestration of the already translated viral RNA in nonfunctional replication complexes or to the use of viral RNA for assembly of new virions. The most striking finding is that the 2A(Y88S) mutant synthesized 10-fold less protein than did the WT poliovirus, under conditions in which the total amount of viral RNA was similar to that of WT poliovirus (Fig. 7A) . These results suggest that the viral RNA is not actively translated in HeLa cells infected by the 2A(Y88S) mutant. Failure of the 2A pro Y88S mutant to transactivate poliovirus leader-luc mRNA. One of the activities ascribed to poliovirus 2A pro is the ability to transactivate the translation of mRNAs bearing the poliovirus 5Ј untranslated sequence (12) . Since the major defect found in the 2A(Y88S) mutant was at the translational level, we sought to analyze the transactivation capacity of both WT poliovirus and the 2A(Y88S) mutant. Two different mRNAs encoding luciferase were assayed, one containing the luciferase gene under the control of the poliovirus leader sequence and the other consisting of a capped mRNA containing the 5Ј leader sequence of the luciferase gene (Fig. 8) . Different transfection protocols were used to assay the transactivation effect; good transactivation was found when cells were first infected with poliovirus and then, after 2 h of poliovirus replication, transfected with mRNA by the lipofectin method. Cells were harvested 3 h after transfection, and extracts were prepared to assay luciferase activity. Notably, infection with WT poliovirus caused an about sixfold increase in luciferase activity when the leader-luc mRNA was analyzed, while no increase was found with the 2A(Y88S) mutant (Fig.  8A ). This stimulation was observed even when the infected cells were treated with guanidine, suggesting that the amount of 2A pro generated by translation of the input RNA is sufficient to transactivate the leader-luc mRNA. As a control, the amount of mRNA transfected into HeLa cells was quantitated. Figure 8B shows that the same leader-luc mRNA was transfected in mock-infected cells, WT poliovirus-infected cells, and 2A(Y88S) mutant-infected cells. These results suggest that the poliovirus 2A pro mutant has a defect in the ability to transactivate the poliovirus leader sequence. Finally, infection by both WT poliovirus and the 2A(Y88S) mutant inhibited luciferase production from the capped luc mRNA, suggesting that the capacity to inhibit translation of capped mRNA is retained in the 2A(Y88S) mutant (Fig. 8) . To assess the action of 2A pro on p220 cleavage during these experiments, the extracts obtained to measure luciferase activity were immunoreacted with p220 antibodies. p220 was cleaved after infection with both WT poliovirus and mutant 2A(Y88S) in the absence or presence of guanidine (Fig. 8C) .
Transactivation of leader-luc mRNA upon transfection with mRNA encoding 2A pro . Once it was determined that infection with mutant 2A(Y88S) did not transactivate translation of leader-luc mRNA, it was of interest to assay transactivation by the isolated 2A pro gene. The sequences corresponding to WT 2A pro were placed under control of the encephalomyocarditis virus 5Ј untranslated region, and the corresponding mRNA was cotransfected with the leader-luc mRNA. Figure 9 shows a 10-fold enhancement of luciferase activity upon transfection with mRNA encoding WT poliovirus 2A 
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leader-luc transactivation was observed with the 2A(Y88L) mutant, and none was seen with the 2A(Y88P) mutant (Fig. 9 ). These findings indicate that transactivation of the poliovirus 5Ј leader sequence by 2A pro can be achieved by cotransfection of the two mRNAs, i.e., leader-luc mRNA and mRNA encoding 2A pro . Moreover, our results point to the crucial role of residue 88 of 2A pro in the transactivation effect. Finally, the possibility that 2A(Y88S) is viable because it still possesses some transactivation activity while 2A(488P) has a null phenotype because it is unable to transactivate is attractive.
DISCUSSION
The availability of the cloned poliovirus genome allows the generation of an increasing number of mutants with changes in virtually all regions of the poliovirus genome (38) . This research is providing a more detailed picture of the mechanisms by which the viral RNA is translated and replicated. However, many fundamental aspects of poliovirus biology remain unclear. It is hoped that manipulation of the cloned poliovirus genome will allow further insight into the poliovirus replication cycle (38) . Analysis of the poliovirus 2A pro mutant described in this work offers several new findings. One important result that emerged from this study is that the effect of the mutation of 2A pro on the capacity to cleave p220 is much better analyzed when the protease is produced in virus-infected cells or in cells transfected with the 2A pro gene than in cell-free systems. Our present results show that p220 is degraded in cells expressing mutant 2A
pro to the same extent as during WT poliovirus infection, a conclusion not reached when cell-free systems were used (42) . Another aspect of this study is that 2A pro can be selectively modified in such a way that the protease is still able to cleave in trans some substrates, such as p220, but not others, such as 3CD. This finding raises the possibility of finding 2A pro mutants with the converse phenotype, i.e., poliovirus mutants selectively unable to cleave p220 that still retain the ability to hydrolyze 3CD. The region of 2A pro located around residue 88 seems to be important in the recognition of substrates in trans, as already indicated by others (42) .
Expression of 2A pro enhances production of luciferase from a transfected reporter plasmid encoding luciferase under control of the poliovirus leader sequence (12) . The mechanism by which 2A pro induces this activation is unknown, but a more detailed analysis of the mutant described here will provide new clues to this activation. We believe that one of the most important characteristics of the 2A(Y88S) mutant described in the present work is that it shows defects in viral protein synthesis, perhaps as a consequence of its failure to transactivate the poliovirus leader sequence (12) . If this is so, our findings demonstrate that the enhancing effect of 2A pro on poliovirus protein synthesis is required for efficient virus growth. There are several possible explanations for the present results. (i) 2A pro directly enhances the translation of poliovirus RNA; this enhancement could be achieved by its potential capacity to bind the viral RNA (10, 20) . (ii) Y88S mutant 2A pro is not only unable to cleave the 3CD substrate but is also unable to cleave an unidentified cellular protein necessary for transactivation of poliovirus RNA translation. (iii) The impairment of translation observed in the Y88S mutant is due to the lack of 3CЈ and/or 3DЈ. The 3CD precursor, unlike 3C pro or 3D pol , has the ability to bind to a specific region at the 3Ј end of poliovirus RNA (2). Thus, it would not be surprising if 3CЈ or 3DЈ showed RNA binding specificity different from that of 3C pro , 3D pol , or 3CD and if this RNA binding potentiated translation in HeLa cells. As already pointed out, the fact that the 3CD cleavage that gives rise to 3CЈ and 3DЈ remains after repeated passage of poliovirus suggests that the formation of these products is important in some step(s) of the poliovirus life cycle (18) . If this is so, this finding means that the alternative cleavage of 3CD has a physiological meaning, providing an extreme example of the compactness of the information in the poliovirus 3CD region. However, we believe, that the third possibility is unlikely, since a poliovirus mutant with an alteration in 3CD which is no longer cleaved by 2A pro shows no growth defects (18) . Moreover, as shown in the present work, transactivation occurs with the transfection of mRNA encoding 2A pro alone, and the 3CЈ and 3DЈ products have not been implicated in this process (12) .
The finding that 2A pro is necessary to stimulate the synthesis of poliovirus proteins (12) provides another example of a virusencoded protein that selectively enhances the translation of some mRNAs from the same virus. Proteins such as rev or NS1 enhance the translation of some human immunodeficiency virus mRNAs or influenza virus mRNAs, respectively (5, 21, 29) . The mechanism of this selective activation lies in the selective binding of these proteins to their corresponding mRNAs (5, 21, 29) . Once the proteins are bound to these mRNAs, the initiation of translation on these messengers is more efficient, perhaps because of the recruitment of initiation complexes on these mRNAs. There are indications that picornavirus 2A possesses the capacity to interact with the leader sequence of the picornavirus mRNA (20) . Since poliovirus 2A
pro enhances the translation of its own mRNA, it could be that binding of 2A pro activates the initiation of the picornavirus mRNA. This is also suggested by the fact that 2A pro needs to interact with p220 to cleave this factor. Moreover, we have found that the C terminus of p220 becomes associated with polysomes in poliovirusinfected cells (unpublished observations). The possibility that cleaved p220, or at least one of its fragments, participates in poliovirus mRNA translation is still open. The interaction of 2A pro with the C-terminal p220 fragment and with the 5Ј leader region of poliovirus RNA would provide a mechanism to account for the selective transactivation of poliovirus translation by 2A pro . Experiments are in progress in our laboratory to assay this model.
